West Coast Financial LLC Has $4.49 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

West Coast Financial LLC raised its position in Encompass Health Co. (NYSE:EHC) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 48,588 shares of the company’s stock after purchasing an additional 917 shares during the period. West Coast Financial LLC’s holdings in Encompass Health were worth $4,487,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC increased its position in shares of Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock valued at $845,000 after acquiring an additional 123 shares during the last quarter. Daiwa Securities Group Inc. acquired a new position in shares of Encompass Health during the 2nd quarter worth approximately $60,000. American Century Companies Inc. raised its stake in shares of Encompass Health by 8.4% during the 2nd quarter. American Century Companies Inc. now owns 468,560 shares of the company’s stock worth $40,198,000 after purchasing an additional 36,130 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in shares of Encompass Health by 72.4% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 9,661 shares of the company’s stock valued at $823,000 after buying an additional 4,056 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Encompass Health by 1.2% in the second quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company’s stock valued at $156,083,000 after buying an additional 22,311 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $93.59 on Thursday. The firm has a 50 day moving average of $97.91 and a 200-day moving average of $93.88. Encompass Health Co. has a 12 month low of $67.94 and a 12 month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $9.43 billion, a PE ratio of 22.61, a PEG ratio of 1.09 and a beta of 0.89.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. During the same period in the previous year, the business earned $0.86 earnings per share. The company’s revenue was up 11.9% on a year-over-year basis. On average, equities research analysts predict that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on EHC. Truist Financial restated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. KeyCorp boosted their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Barclays increased their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Finally, Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.